Yvonne N Flores1,2,3, Jorge Salmerón4,5, Beth A Glenn6,7, Cathy M Lang8, L Cindy Chang7, Roshan Bastani6,7. 1. Unidad de Investigación Epidemiológica y en Servicios de Salud, Instituto Mexicano del Seguro Social, Cuernavaca, Morelos, Mexico. ynflores@ucla.edu. 2. UCLA Department of Health Policy and Management and Kaiser Permanente Center for Health Equity, Fielding School of Public Health, Los Angeles, CA, USA. ynflores@ucla.edu. 3. UCLA Cancer Prevention and Control Research Center, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. ynflores@ucla.edu. 4. Unidad de Investigación Epidemiológica y en Servicios de Salud, Instituto Mexicano del Seguro Social, Cuernavaca, Morelos, Mexico. 5. Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico. 6. UCLA Department of Health Policy and Management and Kaiser Permanente Center for Health Equity, Fielding School of Public Health, Los Angeles, CA, USA. 7. UCLA Cancer Prevention and Control Research Center, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. 8. Department of Community Health Sciences, UCLA Fielding School of Public Health, Los Angeles, CA, USA.
Abstract
OBJECTIVE: To compare the knowledge, beliefs, and practices regarding HPV vaccination among mothers of vaccine-eligible girls in Mexico and the USA. METHODS: Similar samples of Mexican mothers with vaccine-eligible daughters were surveyed at two clinics in Cuernavaca, Morelos, from July to October 2012 (n = 200) and at two clinics in Oxnard, California, from August to November 2013 (n = 200). RESULTS: Although mothers in the USA had less knowledge and more negative attitudes toward the vaccine than their counterparts in Mexico, vaccine uptake rates were higher in the USA (49% vs. 40%). US mothers were more likely to have discussed and been offered the HPV vaccine by a clinician than mothers in Mexico. In multivariate analyses, having been offered the HPV vaccine was the most important predictor of vaccine uptake. CONCLUSIONS: Our results suggest that healthcare access or other system, clinic, or provider factors are the main drivers of vaccine receipt in this binational sample of Mexican mothers. Interventions and programs that encourage clinicians to offer the HPV vaccine should be developed to increase vaccine uptake in both countries.
OBJECTIVE: To compare the knowledge, beliefs, and practices regarding HPV vaccination among mothers of vaccine-eligible girls in Mexico and the USA. METHODS: Similar samples of Mexican mothers with vaccine-eligible daughters were surveyed at two clinics in Cuernavaca, Morelos, from July to October 2012 (n = 200) and at two clinics in Oxnard, California, from August to November 2013 (n = 200). RESULTS: Although mothers in the USA had less knowledge and more negative attitudes toward the vaccine than their counterparts in Mexico, vaccine uptake rates were higher in the USA (49% vs. 40%). US mothers were more likely to have discussed and been offered the HPV vaccine by a clinician than mothers in Mexico. In multivariate analyses, having been offered the HPV vaccine was the most important predictor of vaccine uptake. CONCLUSIONS: Our results suggest that healthcare access or other system, clinic, or provider factors are the main drivers of vaccine receipt in this binational sample of Mexican mothers. Interventions and programs that encourage clinicians to offer the HPV vaccine should be developed to increase vaccine uptake in both countries.
Entities:
Keywords:
Cervical cancer prevention; Health disparities; Human papillomavirus; Latinos; Mexico; Vaccination
Authors: Roshan Bastani; Beth A Glenn; Vicky M Taylor; Moon S Chen; Tung T Nguyen; Susan L Stewart; Annette E Maxwell Journal: Prev Med Date: 2009-08-27 Impact factor: 4.018
Authors: Roshan Bastani; Beth A Glenn; Jennifer Tsui; L Cindy Chang; Erica J Marchand; Victoria M Taylor; Rita Singhal Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-05-20 Impact factor: 4.254
Authors: E C Lazcano-Ponce; S Moss; P Alonso de Ruíz; J Salmerón Castro; M Hernández Avila Journal: Arch Med Res Date: 1999 May-Jun Impact factor: 2.235
Authors: Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger Journal: MMWR Recomm Rep Date: 2007-03-23
Authors: Maria E Fernandez; Sheryl A McCurdy; Sarah R Arvey; Sandra K Tyson; Daisy Morales-Campos; Belinda Flores; Bernardo Useche; Lisa Mitchell-Bennett; Maureen Sanderson Journal: Ethn Health Date: 2009-12 Impact factor: 2.772
Authors: Marjan Javanbakht; Shauna Stahlman; Susan Walker; Sami Gottlieb; Lauri Markowitz; Nicole Liddon; Aaron Plant; Sarah Guerry Journal: Vaccine Date: 2012-05-03 Impact factor: 3.641
Authors: Roshan Bastani; Beth A Glenn; Rita Singhal; Catherine M Crespi; Narissa J Nonzee; Jennifer Tsui; L Cindy Chang; Alison K Herrmann; Victoria M Taylor Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-10-14 Impact factor: 4.090
Authors: Mariel A Oyervides-Muñoz; Antonio A Pérez-Maya; Celia N Sánchez-Domínguez; Anais Berlanga-Garza; Mauro Antonio-Macedo; Lezmes D Valdéz-Chapa; Ricardo M Cerda-Flores; Victor Trevino; Hugo A Barrera-Saldaña; María L Garza-Rodríguez Journal: Viruses Date: 2020-03-31 Impact factor: 5.048